Zeb2 recruits HDAC–NuRD to inhibit Notch and controls Schwann cell differentiation and remyelination

Lai Man Natalie Wu,Jincheng Wang,Andrea Conidi,Chuntao Zhao,Haibo Wang,Zachary Ford,Liguo Zhang,Christiane Zweier,Brian G Ayee,Patrice Maurel,An Zwijsen,Jonah R Chan,Michael P Jankowski,Danny Huylebroeck,Q Richard Lu
DOI: https://doi.org/10.1038/nn.4322
IF: 25
2016-01-01
Nature Neuroscience
Abstract:This study shows that the transcriptional regulator Zeb2 is required for the onset of peripheral myelination and remyelination. Zeb2 recruits HDAC1–HDAC2–NuRD co-repressor complexes to antagonize inhibitory effectors including Notch, while activating promyelinogenic factors. A Mowat-Wilson syndrome–associated ZEB2 mutation disrupting HDAC–NuRD interaction abolishes Zeb2 activity for Schwann cell differentiation.
What problem does this paper attempt to address?